Insider · CIK 0001695378
John Hohneker
Files at CRIS (CURIS INC), AVBP (ArriVent BioPharma, Inc.). First filing -, latest -.
John Hohneker files SEC Form 4 as director at CRIS (CURIS INC), and also at AVBP (ArriVent BioPharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Hohneker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | AVBP ArriVent BioPharma, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +13,562 | $0.00 | $0 | 13,562 | Jun 22, 2026 |
| Jun 18, 2025 | AVBP ArriVent BioPharma, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +15,502 | $0.00 | $0 | 15,502 | Jun 20, 2025 |
| May 20, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +14,400 | $3.13 | $45k | 14,400 | May 22, 2025 |
| Jan 28, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +1,600 | $3.13 | $5,008 | 1,600 | Jan 30, 2025 |
Questions about John Hohneker
Answered from the filings on this page, as of the latest one.
Is John Hohneker buying or selling?
John Hohneker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Hohneker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Hohneker has 0.
Where does John Hohneker file Form 4?
John Hohneker has filed Form 4 at CRIS (CURIS INC); AVBP (ArriVent BioPharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.